In line with the progression, a lower IFNγ score (the average of the genes of the IFNγ signature, −1.937) was detected in the progressive lesion, while the PD-L1 expression on tumor cells was higher in the progressive lesion (10–50% vs. 1–10%) (Table 2). This evidence concerns the gene IFNG and neoplasm.